Dietary and nutritional products affect individuals differently based on their genetic predisposition, nutritional lifestyle, exercises habits, and their environments.
More than 50% of clinical trials currently fail due to low efficacy.
Several markers and tests have been introduced in the market for diagnosing cancer types and other diseases.
Preclinical research, when related to molecular biology data analysis, mostly includes statistical analysis to identify significantly differentiated molecules in the phenotypes under study.
Publishing scientific findings in domain-specific journals and announcing them in scientific conferences has become an essential part of today’s research environment.
November 15, 2019
The new version of InSyBio Suite enables the fast and accurate analysis of omics data by non-bioinformatics experts empowered with novel techniques to explore the dark matter of the transcriptomics data.
October 14, 2019
InSyBio is showcasing as one of 7 prestigious companies during The International Accelerator’s Demo Day taking place October 22nd, 2019 at 4:30pm.
October 1, 2019
In a close collaboration with a prestigious Austin, TX medical center, InSyBio applied its proprietary technology to identify targeted biomarkers to provide an unbiased, non-interventive diagnostic method for Stroke.